Incidences of Chemotherapy-induced Neutropenia and Its Association with Treatment Outcomes
نویسندگان
چکیده
The present study was aimed to evaluate the incidences of chemotherapy-induced neutropenia in patients with solid tumors in India. The patients with carcinomas of breast, lung, ovary, colon, head and neck, and liver were divided in two groups. Group 1 was for the patients who experienced grade 0-2 neutropenia and Group 2 was for patients with grade 3-4 neutropenia. Different types of chemotherapeutic agents were administered to the patients according to the routine practice of the physicians. The study revealed that the incidences of grade 3-4 neutropenia were observed in the patients with the first time exposure of the chemotherapeutic agents as well as the age factor also played an important role in the occurrence of neutropenia and febrile neutropenia. The results of this observational study indicate that the proportion of grade 0-2 neutropenia does not significantly (P-value > 0.05) differ from the hypotheses value (i.e. 50%). Thus, we observed that the proportion of incidence of grade 3-4 neutropenia is less as compare to proportion of grade 0-2 neutropenia. Significant no. of patients received pegylated GCSF while a small proportion of patients received non-pegylated GCSF. A few patients were hospitalized due to neutropenia wherein age was observed as an important factor. Due to neutropenia, age of patients, and other comorbidities, chemotherapy dose was delayed and/or reduced.
منابع مشابه
Main Determinants of Severe Neutropenia in Patients with Solid Tumors Receiving Adjuvant Chemotherapy
Background:Chemotherapy-induced neutropenia as a major toxicity of systemic chemotherapy is commonly associated with substantial mortality and morbidity, and thus identifying its determinants is necessary. This study was undertaken to identify main risk factors of severe neutropenia following adjuvant chemotherapy treatment in a community-based population of patients with cancer in Semnan, I...
متن کاملEffect of chamomile on chemotherapy-induced neutropenia in pediatric leukemia patients: A randomized triple-blind placebo-controlled clinical trial
Objective: Chemotherapy-induced neutropenia is one of the main side effects of acute lymphoblastic leukemia (ALL) treatment. In this trial, we evaluated the efficacy of chamomile in management of neutropenia. Materials and Methods: This randomized triple-blind placebo-controlled clinical trial was carried out in 2-18-year-old children with ALL. Particip...
متن کاملComparing the Efficacy of Ceftazidime and Meropenem in Treatment of Febrile Neutropenia in Pediatric Patients with Cancer
Abstract Background In cancer patients, various infections were developed due to severe neutropenia resulted from chemotherapy. Ceftazidime is commonly used as monotherapy of cancer patients with fever and neutropenia. Meropenem is a new carbapenem with more extended antibacterial spectrum including anaerobes. It provides better coverage against gram positives. This trial compared the efficac...
متن کاملChemotherapy-induced Neutropenia in cancer patients with solid tumors in India
The present study was aimed to evaluate the incidences of chemotherapy-induced neutropenia and febrile neutropenia in the patients with solid tumors in India. The patients with carcinomas of breast, lung, ovary, colon, head and neck, and liver were divided in two groups. Group 1 was for the patients who experienced grade 0-2 neutropenia and Group 2 was for the patients with grade 3-4 neutropeni...
متن کاملAzathioprine induced anagen effluvium and its association with myelosuppression
Dear Editor, Azathioprine, a steroid sparing immunosuppressant, is used in organ transplantation and various immunological diseases like pemphigus vulgaris, pemphigus foliaceous, vitiligo, lichen planus, and alopecia areata. Anagen effluvium (AE) is the abrupt loss of hairs in their growing phase most commonly due to chemotherapy and radiation 1. Azathioprine can cause AE in association with my...
متن کامل